tradmap

XRAY Financials Dentsply Sirona Inc.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 2.0% per year over the past 5 years.
  • Operating margin has contracted, at -11.5% in the latest year.
  • Free cash flow has declined 28.6% per year over the past 5 years.

Financial health

  • Total debt ($2.3B) exceeds cash ($326M); net debt is $1.9B.
  • Total debt has grown in line with revenue (-0.1% vs 2.0% per year).
  • Operating income covered interest expense -4.8× in the latest year.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 123.1% of free cash flow.
  • The dividend has grown 7.8% per year over the past 5 years.
Revenue & net income
-$2B $1B $4B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-39% 8% 55% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $281M $562M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $1B $2B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$2B -$442M $1B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $3.7B -$598M 50.0% -11.5% $104M $2.3B $326M
2024 $3.8B -$910M 51.6% -23.2% $281M $1.7B $272M
2023 $4.0B -$132M 52.6% -2.1% $228M $1.9B $334M
2022 $3.9B -$950M 54.2% -23.9% $368M $1.9B $365M
2021 $4.2B $411M 55.5% 14.4% $515M $1.9B $339M
2020 $3.3B -$73M 49.6% -0.1% $562M $2.3B $438M
2019 $4.0B $256M 53.8% 8.8% $516M $1.4B $405M
2018 $4.0B -$1.0B 51.9% -24.0% $317M $1.6B $310M
2017 $4.0B -$1.6B 54.8% -39.1% $458M $1.6B $321M
2016 — $430M — — $438M $1.5B $384M
2015 — $251M — — $425M $1.2B $285M
2014 — $323M — — $461M $1.3B $152M
2013 — $313M — — $318M $1.4B $75M
2012 — $314M — — $278M $1.5B $80M
2011 — $245M — — $322M $1.5B $77M

Valuation over time

How the market has priced XRAY against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 1.1 2.1 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 3.1 6.1 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is XRAY growing its revenue and profit?

Over the past 5 years, Dentsply Sirona Inc.'s revenue has grown 2.0% per year. These are computed facts, not advice.

How much debt does XRAY have?

As of FY2025, Dentsply Sirona Inc. reported $2.3B of total debt against $326M of cash; operating income covered interest expense -4.8×.

What is XRAY's profit margin?

In FY2025, gross margin was 50.0%, operating margin -11.5%, and net margin -16.3%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.